Health Canada
- Status: approved
Darvocet then placebo then opana (Darvocet then placebo then opana) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
University of Rochester is the originator. The local marketing authorisation holder may differ — check the official source linked above.